[Clinico-etiological and therapeutic aspects of peripheral facial paralysis].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003384:Coxsackievirus Infections / Q000150:complications; D004457:Echovirus Infections / Q000150:complications; D005158:Facial Paralysis / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008417:Mastoiditis / Q000150:complications; D010031:Otitis / Q000150:complications; D011051:Poliomyelitis / Q000150:complications; D014803:Vitamin B Complex / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D014803:Vitamin B Complex; D000324:Adrenocorticotropic Hormone; D001205:Ascorbic Acid
Aspecte clinico-etiologice şi terapeutice ale paraliziei faciale periferice.